nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezogabine—NAT2—urine—polycystic ovary syndrome	0.151	0.393	CbGeAlD
Ezogabine—UGT1A1—urine—polycystic ovary syndrome	0.0561	0.146	CbGeAlD
Ezogabine—NAT2—endocrine gland—polycystic ovary syndrome	0.0251	0.0652	CbGeAlD
Ezogabine—KCNQ5—vagina—polycystic ovary syndrome	0.0228	0.0593	CbGeAlD
Ezogabine—KCNQ2—pituitary gland—polycystic ovary syndrome	0.0204	0.0529	CbGeAlD
Ezogabine—UGT1A3—endocrine gland—polycystic ovary syndrome	0.019	0.0494	CbGeAlD
Ezogabine—KCNQ2—female gonad—polycystic ovary syndrome	0.017	0.044	CbGeAlD
Ezogabine—UGT1A4—endocrine gland—polycystic ovary syndrome	0.0162	0.042	CbGeAlD
Ezogabine—KCNQ2—endocrine gland—polycystic ovary syndrome	0.0158	0.041	CbGeAlD
Ezogabine—UGT1A9—endocrine gland—polycystic ovary syndrome	0.0136	0.0352	CbGeAlD
Ezogabine—CYP2A6—adipose tissue—polycystic ovary syndrome	0.0101	0.0262	CbGeAlD
Ezogabine—UGT1A1—endocrine gland—polycystic ovary syndrome	0.0093	0.0241	CbGeAlD
Ezogabine—CYP2A6—vagina—polycystic ovary syndrome	0.00837	0.0217	CbGeAlD
Ezogabine—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00387	0.0496	CcSEcCtD
Ezogabine—Influenza—Metformin—polycystic ovary syndrome	0.00362	0.0465	CcSEcCtD
Ezogabine—Neutropenia—Metformin—polycystic ovary syndrome	0.00339	0.0434	CcSEcCtD
Ezogabine—Infestation NOS—Metformin—polycystic ovary syndrome	0.00323	0.0414	CcSEcCtD
Ezogabine—Infestation—Metformin—polycystic ovary syndrome	0.00323	0.0414	CcSEcCtD
Ezogabine—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00305	0.0392	CcSEcCtD
Ezogabine—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00286	0.0366	CcSEcCtD
Ezogabine—Eye disorder—Metformin—polycystic ovary syndrome	0.00271	0.0348	CcSEcCtD
Ezogabine—Malnutrition—Metformin—polycystic ovary syndrome	0.00252	0.0324	CcSEcCtD
Ezogabine—Muscle spasms—Metformin—polycystic ovary syndrome	0.00243	0.0311	CcSEcCtD
Ezogabine—Vision blurred—Metformin—polycystic ovary syndrome	0.00238	0.0305	CcSEcCtD
Ezogabine—Tremor—Metformin—polycystic ovary syndrome	0.00236	0.0303	CcSEcCtD
Ezogabine—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00234	0.03	CcSEcCtD
Ezogabine—Malaise—Metformin—polycystic ovary syndrome	0.00228	0.0292	CcSEcCtD
Ezogabine—Syncope—Metformin—polycystic ovary syndrome	0.00226	0.029	CcSEcCtD
Ezogabine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00222	0.0285	CcSEcCtD
Ezogabine—Discomfort—Metformin—polycystic ovary syndrome	0.00212	0.0272	CcSEcCtD
Ezogabine—Infection—Metformin—polycystic ovary syndrome	0.00205	0.0262	CcSEcCtD
Ezogabine—Shock—Metformin—polycystic ovary syndrome	0.00203	0.026	CcSEcCtD
Ezogabine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00202	0.0259	CcSEcCtD
Ezogabine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00202	0.0259	CcSEcCtD
Ezogabine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00199	0.0255	CcSEcCtD
Ezogabine—Paraesthesia—Metformin—polycystic ovary syndrome	0.00185	0.0237	CcSEcCtD
Ezogabine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00184	0.0236	CcSEcCtD
Ezogabine—Somnolence—Metformin—polycystic ovary syndrome	0.00183	0.0235	CcSEcCtD
Ezogabine—Dyspepsia—Metformin—polycystic ovary syndrome	0.00181	0.0233	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00178	0.0228	CcSEcCtD
Ezogabine—Fatigue—Metformin—polycystic ovary syndrome	0.00178	0.0228	CcSEcCtD
Ezogabine—Constipation—Metformin—polycystic ovary syndrome	0.00176	0.0226	CcSEcCtD
Ezogabine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.0017	0.0218	CcSEcCtD
Ezogabine—Asthenia—Metformin—polycystic ovary syndrome	0.00148	0.019	CcSEcCtD
Ezogabine—Dizziness—Metformin—polycystic ovary syndrome	0.00136	0.0175	CcSEcCtD
Ezogabine—Rash—Metformin—polycystic ovary syndrome	0.0013	0.0167	CcSEcCtD
Ezogabine—Dermatitis—Metformin—polycystic ovary syndrome	0.0013	0.0166	CcSEcCtD
Ezogabine—Nausea—Metformin—polycystic ovary syndrome	0.00122	0.0157	CcSEcCtD
Ezogabine—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—polycystic ovary syndrome	0.000971	0.00181	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000965	0.0018	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000955	0.00178	CbGpPWpGaD
Ezogabine—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000954	0.00178	CbGpPWpGaD
Ezogabine—UGT1A3—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000952	0.00177	CbGpPWpGaD
Ezogabine—UGT1A9—PPARA activates gene expression—CYP1A1—polycystic ovary syndrome	0.00094	0.00175	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000939	0.00175	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000939	0.00175	CbGpPWpGaD
Ezogabine—UGT1A3—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000939	0.00175	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000921	0.00172	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—SUOX—polycystic ovary syndrome	0.000921	0.00172	CbGpPWpGaD
Ezogabine—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—polycystic ovary syndrome	0.00092	0.00171	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—STAR—polycystic ovary syndrome	0.000911	0.0017	CbGpPWpGaD
Ezogabine—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000878	0.00163	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000856	0.00159	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000855	0.00159	CbGpPWpGaD
Ezogabine—UGT1A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000854	0.00159	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—NMNAT3—polycystic ovary syndrome	0.000837	0.00156	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000816	0.00152	CbGpPWpGaD
Ezogabine—UGT1A1—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000816	0.00152	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—HMMR—polycystic ovary syndrome	0.000812	0.00151	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000806	0.0015	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000806	0.0015	CbGpPWpGaD
Ezogabine—UGT1A1—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000805	0.0015	CbGpPWpGaD
Ezogabine—UGT1A9—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000805	0.0015	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000795	0.00148	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000787	0.00147	CbGpPWpGaD
Ezogabine—UGT1A1—NRF2 pathway—NRG1—polycystic ovary syndrome	0.000776	0.00145	CbGpPWpGaD
Ezogabine—UGT1A9—NRF2 pathway—NRG1—polycystic ovary syndrome	0.000776	0.00145	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000774	0.00144	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—LPCAT2—polycystic ovary syndrome	0.000766	0.00143	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—SUOX—polycystic ovary syndrome	0.000766	0.00143	CbGpPWpGaD
Ezogabine—CYP2A6—NRF2 pathway—SLC2A4—polycystic ovary syndrome	0.000763	0.00142	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000746	0.00139	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000728	0.00136	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000728	0.00136	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ISYNA1—polycystic ovary syndrome	0.000712	0.00133	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000712	0.00133	CbGpPWpGaD
Ezogabine—CYP2A6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000712	0.00133	CbGpPWpGaD
Ezogabine—UGT1A9—PPARA activates gene expression—PPARG—polycystic ovary syndrome	0.000711	0.00132	CbGpPWpGaD
Ezogabine—UGT1A3—Biological oxidations—POMC—polycystic ovary syndrome	0.00071	0.00132	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—LHB—polycystic ovary syndrome	0.000706	0.00132	CbGpPWpGaD
Ezogabine—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—polycystic ovary syndrome	0.000696	0.0013	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—HSD3B2—polycystic ovary syndrome	0.00069	0.00129	CbGpPWpGaD
Ezogabine—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—polycystic ovary syndrome	0.000669	0.00125	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000669	0.00125	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—LEP—polycystic ovary syndrome	0.000663	0.00123	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—LEP—polycystic ovary syndrome	0.000663	0.00123	CbGpPWpGaD
Ezogabine—UGT1A1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000658	0.00122	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000658	0.00122	CbGpPWpGaD
Ezogabine—UGT1A1—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000649	0.00121	CbGpPWpGaD
Ezogabine—UGT1A9—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000649	0.00121	CbGpPWpGaD
Ezogabine—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—polycystic ovary syndrome	0.000634	0.00118	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000629	0.00117	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000615	0.00115	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.00061	0.00114	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—AKR1C2—polycystic ovary syndrome	0.000605	0.00113	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—TEAD2—polycystic ovary syndrome	0.000605	0.00113	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000605	0.00113	CbGpPWpGaD
Ezogabine—CYP2A6—NRF2 pathway—NRG1—polycystic ovary syndrome	0.000598	0.00111	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—RRM2—polycystic ovary syndrome	0.000596	0.00111	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000578	0.00108	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000578	0.00108	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—NMNAT3—polycystic ovary syndrome	0.000578	0.00108	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—PPARG—polycystic ovary syndrome	0.000578	0.00108	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—PPARG—polycystic ovary syndrome	0.000578	0.00108	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—YAP1—polycystic ovary syndrome	0.000574	0.00107	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—INS—polycystic ovary syndrome	0.000566	0.00106	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—INS—polycystic ovary syndrome	0.000566	0.00106	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—STAR—polycystic ovary syndrome	0.000552	0.00103	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—NAMPT—polycystic ovary syndrome	0.000552	0.00103	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000552	0.00103	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—AKT2—polycystic ovary syndrome	0.000548	0.00102	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—AKT2—polycystic ovary syndrome	0.000548	0.00102	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000545	0.00102	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000539	0.001	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—LPCAT2—polycystic ovary syndrome	0.000529	0.000985	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—SUOX—polycystic ovary syndrome	0.000529	0.000985	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000529	0.000985	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—SUOX—polycystic ovary syndrome	0.000529	0.000985	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000522	0.000973	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000515	0.000959	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PNPLA2—polycystic ovary syndrome	0.000507	0.000945	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000507	0.000944	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000507	0.000944	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—VEGFA—polycystic ovary syndrome	0.000502	0.000934	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—VEGFA—polycystic ovary syndrome	0.000502	0.000934	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—HMMR—polycystic ovary syndrome	0.000492	0.000916	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000492	0.000916	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ISYNA1—polycystic ovary syndrome	0.000492	0.000916	CbGpPWpGaD
Ezogabine—UGT1A1—Biological oxidations—POMC—polycystic ovary syndrome	0.00049	0.000913	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—POMC—polycystic ovary syndrome	0.00049	0.000913	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—SRD5A1—polycystic ovary syndrome	0.000481	0.000896	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000481	0.000895	CbGpPWpGaD
Ezogabine—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—polycystic ovary syndrome	0.000479	0.000893	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000469	0.000874	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—STAR—polycystic ovary syndrome	0.000459	0.000854	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000449	0.000836	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NMNAT3—polycystic ovary syndrome	0.000446	0.000831	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—TH—polycystic ovary syndrome	0.000438	0.000816	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—LHB—polycystic ovary syndrome	0.000428	0.000797	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000426	0.000794	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000426	0.000793	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—AKR1C2—polycystic ovary syndrome	0.000418	0.000779	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—HSD3B2—polycystic ovary syndrome	0.000418	0.000779	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000418	0.000779	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—TEAD2—polycystic ovary syndrome	0.000418	0.000779	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—TEAD2—polycystic ovary syndrome	0.000418	0.000779	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—HMMR—polycystic ovary syndrome	0.000409	0.000761	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SUOX—polycystic ovary syndrome	0.000408	0.00076	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—LPCAT2—polycystic ovary syndrome	0.000408	0.00076	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—AKR1C1—polycystic ovary syndrome	0.000405	0.000754	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000402	0.000749	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000401	0.000747	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000396	0.000737	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—HSD3B1—polycystic ovary syndrome	0.00039	0.000726	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ISYNA1—polycystic ovary syndrome	0.000379	0.000706	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—POMC—polycystic ovary syndrome	0.000378	0.000704	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—SULT2A1—polycystic ovary syndrome	0.000373	0.000694	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—RRM2—polycystic ovary syndrome	0.000361	0.000672	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000358	0.000667	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000358	0.000667	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—GNAS—polycystic ovary syndrome	0.000358	0.000667	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—LHB—polycystic ovary syndrome	0.000356	0.000662	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PNPLA2—polycystic ovary syndrome	0.00035	0.000653	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PNPLA2—polycystic ovary syndrome	0.00035	0.000653	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—YAP1—polycystic ovary syndrome	0.000348	0.000648	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—HSD3B2—polycystic ovary syndrome	0.000348	0.000647	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—IL6—polycystic ovary syndrome	0.000347	0.000646	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—IL6—polycystic ovary syndrome	0.000347	0.000646	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—NCOR1—polycystic ovary syndrome	0.000341	0.000635	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—AKR1C1—polycystic ovary syndrome	0.000337	0.000627	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—NAMPT—polycystic ovary syndrome	0.000334	0.000623	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000332	0.000619	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—SRD5A1—polycystic ovary syndrome	0.000332	0.000619	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CYP11A1—polycystic ovary syndrome	0.00033	0.000615	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CYP1A1—polycystic ovary syndrome	0.000323	0.000602	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—AKR1C2—polycystic ovary syndrome	0.000322	0.0006	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—TEAD2—polycystic ovary syndrome	0.000322	0.0006	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—STAR—polycystic ovary syndrome	0.000317	0.00059	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—STAR—polycystic ovary syndrome	0.000317	0.00059	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000313	0.000583	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—AKR1C3—polycystic ovary syndrome	0.000312	0.000581	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—SULT2A1—polycystic ovary syndrome	0.00031	0.000577	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CYP17A1—polycystic ovary syndrome	0.000307	0.000572	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—MTHFR—polycystic ovary syndrome	0.000301	0.000561	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—RRM2—polycystic ovary syndrome	0.0003	0.000559	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—YAP1—polycystic ovary syndrome	0.000289	0.000539	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—HMMR—polycystic ovary syndrome	0.000283	0.000526	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—HMMR—polycystic ovary syndrome	0.000283	0.000526	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—NAMPT—polycystic ovary syndrome	0.000278	0.000518	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP11A1—polycystic ovary syndrome	0.000274	0.000511	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PNPLA2—polycystic ovary syndrome	0.00027	0.000503	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—HSD3B1—polycystic ovary syndrome	0.00027	0.000502	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—HSD3B1—polycystic ovary syndrome	0.00027	0.000502	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000266	0.000496	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—TH—polycystic ovary syndrome	0.000266	0.000495	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—AKR1C3—polycystic ovary syndrome	0.000259	0.000483	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—SLC2A4—polycystic ovary syndrome	0.000258	0.000481	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000256	0.000477	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP17A1—polycystic ovary syndrome	0.000255	0.000475	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000253	0.00047	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—IL6—polycystic ovary syndrome	0.000248	0.000461	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—IL6—polycystic ovary syndrome	0.000248	0.000461	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—LHB—polycystic ovary syndrome	0.000246	0.000458	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—LHB—polycystic ovary syndrome	0.000246	0.000458	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PPARG—polycystic ovary syndrome	0.000244	0.000455	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—STAR—polycystic ovary syndrome	0.000244	0.000455	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CYP19A1—polycystic ovary syndrome	0.000243	0.000452	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—POMC—polycystic ovary syndrome	0.000241	0.000449	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—HSD3B2—polycystic ovary syndrome	0.00024	0.000447	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—HSD3B2—polycystic ovary syndrome	0.00024	0.000447	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—INS—polycystic ovary syndrome	0.00024	0.000446	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—AKR1C1—polycystic ovary syndrome	0.000233	0.000433	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000233	0.000433	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—TH—polycystic ovary syndrome	0.000221	0.000411	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HMMR—polycystic ovary syndrome	0.000218	0.000406	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GNAS—polycystic ovary syndrome	0.000217	0.000404	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—SLC2A4—polycystic ovary syndrome	0.000215	0.0004	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—SULT2A1—polycystic ovary syndrome	0.000214	0.000399	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000214	0.000399	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000208	0.000387	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—RRM2—polycystic ovary syndrome	0.000207	0.000386	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—RRM2—polycystic ovary syndrome	0.000207	0.000386	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—NCOR1—polycystic ovary syndrome	0.000207	0.000385	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP19A1—polycystic ovary syndrome	0.000202	0.000376	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—YAP1—polycystic ovary syndrome	0.0002	0.000372	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—YAP1—polycystic ovary syndrome	0.0002	0.000372	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CYP1A1—polycystic ovary syndrome	0.000196	0.000365	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—NAMPT—polycystic ovary syndrome	0.000192	0.000358	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—NAMPT—polycystic ovary syndrome	0.000192	0.000358	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000191	0.000356	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP11A1—polycystic ovary syndrome	0.00019	0.000353	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP11A1—polycystic ovary syndrome	0.00019	0.000353	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—LHB—polycystic ovary syndrome	0.000189	0.000353	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000188	0.000351	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000185	0.000345	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—MTHFR—polycystic ovary syndrome	0.000183	0.00034	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GNAS—polycystic ovary syndrome	0.00018	0.000336	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—AKR1C1—polycystic ovary syndrome	0.000179	0.000334	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—AKR1C3—polycystic ovary syndrome	0.000179	0.000334	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000179	0.000334	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000176	0.000328	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP17A1—polycystic ovary syndrome	0.000176	0.000328	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—NCOR1—polycystic ovary syndrome	0.000172	0.00032	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SULT2A1—polycystic ovary syndrome	0.000165	0.000307	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP1A1—polycystic ovary syndrome	0.000163	0.000303	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—RRM2—polycystic ovary syndrome	0.00016	0.000298	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—YAP1—polycystic ovary syndrome	0.000154	0.000287	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—TH—polycystic ovary syndrome	0.000153	0.000284	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—TH—polycystic ovary syndrome	0.000153	0.000284	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—MTHFR—polycystic ovary syndrome	0.000152	0.000283	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—SLC2A4—polycystic ovary syndrome	0.000148	0.000276	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000148	0.000276	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PPARG—polycystic ovary syndrome	0.000148	0.000276	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NAMPT—polycystic ovary syndrome	0.000148	0.000276	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP11A1—polycystic ovary syndrome	0.000146	0.000272	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—POMC—polycystic ovary syndrome	0.000146	0.000272	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—INS—polycystic ovary syndrome	0.000145	0.00027	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP19A1—polycystic ovary syndrome	0.00014	0.00026	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP19A1—polycystic ovary syndrome	0.00014	0.00026	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—AKR1C3—polycystic ovary syndrome	0.000138	0.000257	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP17A1—polycystic ovary syndrome	0.000136	0.000253	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GNAS—polycystic ovary syndrome	0.000125	0.000232	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GNAS—polycystic ovary syndrome	0.000125	0.000232	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PPARG—polycystic ovary syndrome	0.000123	0.000229	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—POMC—polycystic ovary syndrome	0.000121	0.000226	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—INS—polycystic ovary syndrome	0.000121	0.000225	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—NCOR1—polycystic ovary syndrome	0.000119	0.000221	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—NCOR1—polycystic ovary syndrome	0.000119	0.000221	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—TH—polycystic ovary syndrome	0.000118	0.000219	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SLC2A4—polycystic ovary syndrome	0.000114	0.000213	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP1A1—polycystic ovary syndrome	0.000112	0.000209	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000112	0.000209	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP19A1—polycystic ovary syndrome	0.000108	0.0002	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—MTHFR—polycystic ovary syndrome	0.000105	0.000195	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—MTHFR—polycystic ovary syndrome	0.000105	0.000195	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GNAS—polycystic ovary syndrome	9.6e-05	0.000179	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NCOR1—polycystic ovary syndrome	9.15e-05	0.00017	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP1A1—polycystic ovary syndrome	8.67e-05	0.000161	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PPARG—polycystic ovary syndrome	8.5e-05	0.000158	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PPARG—polycystic ovary syndrome	8.5e-05	0.000158	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—POMC—polycystic ovary syndrome	8.39e-05	0.000156	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—POMC—polycystic ovary syndrome	8.39e-05	0.000156	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—INS—polycystic ovary syndrome	8.34e-05	0.000155	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—INS—polycystic ovary syndrome	8.34e-05	0.000155	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—MTHFR—polycystic ovary syndrome	8.08e-05	0.000151	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PPARG—polycystic ovary syndrome	6.55e-05	0.000122	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—POMC—polycystic ovary syndrome	6.46e-05	0.00012	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—INS—polycystic ovary syndrome	6.43e-05	0.00012	CbGpPWpGaD
